Company Filing History:
Years Active: 2002-2015
Title: The Innovative Contributions of Cyrus Tabatabay
Introduction
Cyrus Tabatabay is a notable inventor based in Bernex, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance the efficacy of therapeutic agents. With a total of two patents to his name, Tabatabay's work reflects a commitment to advancing medical science.
Latest Patents
Tabatabay's latest patents include innovative formulations aimed at improving the delivery and effectiveness of monoclonal antibodies. One of his patents focuses on "Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs." This invention is directed towards combination formulations of monoclonal antibodies with anti-inflammatory agents, along with related methods and uses. Another significant patent is for "Pharmaceutical compositions containing buffered ortho ester polymers." This composition is designed for the controlled release of therapeutic agents from carboxylic acid ortho ester polymers, which includes a pharmaceutically acceptable salt of an acid that forms a buffer system in a physiologically acceptable pH range.
Career Highlights
Throughout his career, Cyrus Tabatabay has worked with prominent organizations, including Allergan Sales, Inc. and Université de Genève. His experience in these institutions has allowed him to collaborate on various projects that push the boundaries of pharmaceutical research and development.
Collaborations
Some of his notable coworkers include Robert Gurny and Monia Zignani. Their collaborative efforts have contributed to the advancement of innovative solutions in the pharmaceutical industry.
Conclusion
Cyrus Tabatabay's contributions to pharmaceutical formulations demonstrate his dedication to innovation and improvement in medical treatments. His patents reflect a deep understanding of the complexities involved in drug delivery systems, making him a valuable figure in the field.